CORC

在结果中检索

CORC

浏览/检索结果: 共11条，第1-10条 帮助

已选(0)清除 条数/页：   排序方式：
A 36-week multicenter, randomized, double-blind, placebo-controlled, parallel-group, phase 3 clinical trial of sodium oligomannate for mild-to-moderate Alzheimer’s dementia 期刊论文
Alzheimer's Research & Therapy, 2021, 卷号: 13, 期号: 1
作者:  Xiao,Shifu;  Chan,Piu;  Wang,Tao;  Hong,Zhen;  Wang,Shuzhen
收藏  |  浏览/下载：160/0  |  提交时间：2021/05/24
区域劳动加值之资源整合模式建立研究 期刊论文
劳动及职业安全卫生研究季刊, 2018, 卷号: 第26卷 第1期, 页码: 38-48
作者:  陈亭伊;  谢杏慧;  林汉明;  陈怡昌;  黄招宪
收藏  |  浏览/下载：2/0  |  提交时间：2019/12/26
A multicenter, randomized, open-label, phase II trial of erlotinib versus etoposide plus cisplatin with concurrent radiotherapy in unresectable stage III non-small cell lung cancer (NSCLC) with epidermal growth factor receptor (EGFR) activating mutation. 会议论文
作者:  Xing, Ligang;  Wu, Gang;  Wang, Lvhua;  Li, Jian-Cheng;  Wang, Jianhua
收藏  |  浏览/下载：4/0  |  提交时间：2019/12/05
A multicenter, randomized, open-label, phase II trial of erlotinib versus etoposide plus cisplatin with concurrent radiotherapy in unresectable stage III non-small cell lung cancer (NSCLC) with epidermal growth factor receptor (EGFR) activating m 会议论文
JOURNAL OF CLINICAL ONCOLOGY, 2017-05-20
作者:  Xing, Ligang;  Wu, Gang;  Wang, Lvhua;  Li, Jian-Cheng;  Wang, Jianhua
收藏  |  浏览/下载：3/0  |  提交时间：2020/01/04
A multicenter, randomized, open-label, phase II trial of erlotinib versus etoposide plus cisplatin with concurrent radiotherapy in unresectable stage III non-small cell lung cancer (NSCLC) with epidermal growth factor receptor (EGFR) activating m 期刊论文
2017, 卷号: 35
作者:  Xing, Ligang;  Wu, Gang;  Wang, Lvhua;  Li, Jian-Cheng;  Wang, Jianhua
收藏  |  浏览/下载：4/0  |  提交时间：2020/01/04
High performance cast magnesium rare-earth alloys: retrospect and prospect 期刊论文
2016, 卷号: 30, 页码: 1-9
作者:  Chen, Qiaowang[1,2];  Tang, Aitao[1];  Xu, Tingyi[1];  Wang, Yurong[1];  Ye, Junhua[1]
收藏  |  浏览/下载：2/0  |  提交时间：2019/11/29
Synergistic effect of bifunctional Co-TiO2 catalyst on degradation of Rhodamine B: Fenton-photo hybrid process 期刊论文
2013, 卷号: 229, 页码: 57-65
作者:  Chen, Qingkong[1];  Ji, Fangying[1];  Liu, Tingyi[1];  Yan, Peng[1];  Guan, Wei[1]
收藏  |  浏览/下载：4/0  |  提交时间：2019/11/28
A MULTICENTER, RANDOMIZED, OPEN-LABEL, PHASE II TRIAL OF ERLOTINIBVERSUS ETOPOSIDEPLUS CISPLATINWITH CONCURRENT RADIOTHERAPY IN UNRESECTABLESTAGE III NON-SMALLCELL LUNG CANCER (NSCLC) WITH ACTIVATING MUTATION OF EPIDERMAL GROWTH FACTOR RECEPTOR (EGFR) IN EXON 19 OR 21(RECEL, ML28545, NCT01714908) 会议论文
作者:  Xing, Ligang;  Zhuo, Minglei;  Wang, Lvhua;  Chen, Ming;  Ma, Shenglin
收藏  |  浏览/下载：2/0  |  提交时间：2019/12/19
Critical regulation of miR-200/ZEB2 pathway in Oct4/Sox2-induced mesenchymal-to-epithelial transition and induced pluripotent stem cell generation 期刊论文
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2013, 卷号: 110, 期号: 8
作者:  Wang, Guiying;  Guo, Xudong;  Hong, Wujun;  Liu, Qidong;  Wei, Tingyi
收藏  |  浏览/下载：4/0  |  提交时间：2019/12/19
A MULTICENTER, RANDOMIZED, OPEN-LABEL, PHASE II TRIAL OF ERLOTINIBVERSUS ETOPOSIDEPLUS CISPLATINWITH CONCURRENT RADIOTHERAPY IN UNRESECTABLESTAGE III NON-SMALLCELL LUNG CANCER (NSCLC) WITH ACTIVATING MUTATION OF EPIDERMAL GROWTH FACTOR RECEPTOR ( 期刊论文
2013, 卷号: 8, 页码: S559-S560
作者:  Xing, Ligang;  Zhuo, Minglei;  Wang, Lvhua;  Chen, Ming;  Ma, Shenglin
收藏  |  浏览/下载：6/0  |  提交时间：2020/01/13

©版权所有 ©2017 CSpace - Powered by CSpace